Menu
Search
|

Menu

Close
X

Collplant Holdings Ltd CLGN.OQ (NASDAQ Stock Exchange Capital Market)

5.12 USD
-0.16 (-3.03%)
As of 8:51 PM IST
chart
Previous Close 5.28
Open 5.20
Volume 1,450
3m Avg Volume 1,605
Today’s High 5.20
Today’s Low 5.12
52 Week High 10.19
52 Week Low 5.02
Shares Outstanding (mil) 133.54
Market Capitalization (mil) 77.85
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, ILS)
FY18
1
FY17
2
FY16
0
FY15
0
EPS (ILS)
FY18
-0.042
FY17
-0.158
FY16
-0.280
FY15
-0.230
*Note: Units in Millions of Shekel
**Note: Units in Shekel

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
104.50
5.73
Price to Book (MRQ)
vs sector
14.47
5.45
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
0.00
16.72
LT Debt to Equity (MRQ)
vs sector
0.00
12.39
Return on Investment (TTM)
vs sector
-200.14
14.61
Return on Equity (TTM)
vs sector
-226.85
16.34

EXECUTIVE LEADERSHIP

David Tsur
Chairman of the Board, Since 2018
Salary: --
Bonus: --
Yehiel Tal
Chief Executive Officer, Since 2010
Salary: --
Bonus: --
Talya Zavchon
Finance Director, Since 2017
Salary: --
Bonus: --
Oded Shoseyov
Chief Scientific Officer, Since 2016
Salary: --
Bonus: --
Eran Rotem
Vice President - Finance, Since 2012
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

3 Sapir St., Weizmann Sciences P
P.O. Box 4132
NESS-ZIONA     7403626

Phone: +9727.32325600

Collplant holdings Ltd is an Israel-based company active in the medical sector. It produces recombinant human collagen from tobacco plants. Its biomaterials-based products are applicable in medical markets, including orthopedics, wound management, cardiology and general surgery.

SPONSORED STORIES